Abstract:Background: Non-injectable delivery of peptides and proteins are not feasible due to its large molecular, high hydrophilic and gastrointestinal degradation. Therefore, proposing a new method to solve this problem is a burning issue. Purpose: The objective of this study was to propose a novel protein delivery strategy to vanquish the poor efficacy of buccal mucosa delivery systems for protein delivery and then investigate the detailed mechanisms of the enhanced buccal delivery of protein, using insulin as a model drug. Materials and methods: Insulin-phospholipid complex combined with deformable nanovesicles (IPC-DNVs) were prepared, using deformable nanovesicles based on insulin (INS-DNVs) and conventional nanovesicles based on insulin-phospholipid complex (IPC-NVs) as references. Besides, their physicochemical characterization, in vitro transport behavior, in vivo bioactivity and hypoglycemic effect were systematically characterized and compared. Finally, we evaluated the in vivo safety of IPC-DNVs. Results: First, IPC-DNVs increased insulin permeability through deposition of the IPC and deformability of the DNVs, which was revealed by an in vitro mucosal permeation study. Second, DNVs could act as a drug carrier and penetrate the mucosa to reach the receiver medium as intact nanovesicles, which was supported by the observation of intact nanovesicles in the receiver medium through transmission electron microscopy (TEM). Third, IPC-DNVs exhibited both transcellular and paracellular transport in the form of IPC and DNVs, respectively, which was proved by confocal laser scanning microscopy (CLSM). Unlike the other two formulations, IPC-DNVs exhibited a sustained mild hypoglycemic effect, with a relative bioavailability (Fp) of 15.53% (3.09% and 1.96% for INS-DNVs and IPC-NVs, respectively). Furthermore, buccal administration of IPC-DNVs resulted in no visible mucosal irritation to the buccal mucosa. Conclusion: Our work reveals the mechanisms underlying the enhanced buccal delivery of IPC-DNVs: the DNVs facilitate penetration through the main barrier, and the deposition of IPC enhances buccal absorption. Our results and proposed mechanisms could be an important reference to understand other nanocarriers based on protein (peptide)-phospholipid complexes that penetrate the mucosa and provide a theoretical basis for the future development of buccal delivery systems for insulin.

Study on a Nanoparticle System for Buccal Delivery of Insulin.

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

STUDIES ON BUCCAL DELIVERY OF INSULIN FLEXIBLE NANOLIPOSOMES

A nano-delivery system based on preventing degradation and promoting absorption to improve the oral bioavailability of insulin

Goblet Cell-Targeting Nanoparticles for Oral Insulin Delivery and the Influence of Mucus on Insulin Transport

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Insulin Nanoparticles for Transdermal Delivery: Preparation and Physicochemical Characterization and in Vitro Evaluation

Microparticles Based on Alginate/chitosan/casein Three‐dimensional System for Oral Insulin Delivery

Hypoglycaemic effect of a novel insulin buccal formulation on rabbits.

Novel Solid Lipid Nanoparticles As Carriers for Oral Administration of Insulin.

In Situ Rearranged Multifunctional Lipid Nanoparticles Via Synergistic Potentiation for Oral Insulin Delivery.

Preparation and evaluation of insulin-loaded nanoparticles based on hydroxypropyl-β-cyclodextrin modified carboxymethyl chitosan for oral delivery

Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid

Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies

Selenium Nanoparticles As Versatile Carriers for Oral Delivery of Insulin: Insight into the Synergic Antidiabetic Effect and Mechanism

Intranasal delivery of insulin by self-emulsified nanoemulsion system: In vitro and in vivo studies

Study on Oral Insulin Nano-Matrix Drug Delivery System

Dual Stimuli-Responsive Nanoparticle-Incorporated Hydrogels As an Oral Insulin Carrier for Intestine-Targeted Delivery and Enhanced Paracellular Permeation.

Mechanisms of deformable nanovesicles based on insulin-phospholipid complex for enhancing buccal delivery of insulin

Polysaccharide-Based Nanoparticles Equipped with Glucose Oxidase for in Vivo Insulin Delivery

Advancements in Oral Insulin: A Century of Research and the Emergence of Targeted Nanoparticle Strategies